Distinguished in Angiosarcoma

Dr. Imran Zoberi

Radiation Oncology
Washington University
4921 Parkview Pl, Lowr Lvl, 
Saint Louis, MO 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Distinguished in Angiosarcoma
Washington University
4921 Parkview Pl, Lowr Lvl, 
Saint Louis, MO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Imran Zoberi is a Radiation Oncologist in Saint Louis, Missouri. Dr. Zoberi is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Breast Cancer, Angiosarcoma, Adult Soft Tissue Sarcoma, and Undifferentiated Pleomorphic Sarcoma. Dr. Zoberi is currently accepting new patients.

His clinical research consists of co-authoring 54 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles and participated in 1 clinical trial in the study of Angiosarcoma.

Specialties
Radiation Oncology
Licenses
Radiology in MO
Hospital Affiliations
Barnes-Jewish West County Hospital
Barnes Jewish Hospital
Missouri Baptist Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Cox Health
  • EPO
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

WASHINGTON UNIVERSITY
4921 Parkview Pl, Lowr Lvl, Saint Louis, MO 63110

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma
Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma
Enrollment Status: Recruiting
Publish Date: December 06, 2024
Intervention Type: Drug, Radiation, Procedure
Study Drug: Paclitaxel
Study Phase: Phase 1/Phase 2
A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
Enrollment Status: Completed
Publish Date: October 15, 2025
Intervention Type: Radiation, Procedure
Study Phase: Phase 2/Phase 3
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
Enrollment Status: Active_not_recruiting
Publish Date: October 08, 2025
Intervention Type: Other, Radiation
Study Phase: Phase 3
Evaluation of Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma - BreaStBRT
Evaluation of Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma - BreaStBRT
Enrollment Status: Active_not_recruiting
Publish Date: May 07, 2025
Intervention Type: Radiation
Study Phase: Not Applicable
Evaluation of Three Fraction Accelerated Partial Breast Irradiation as the Sole Method of Radiation Therapy for Low-risk Stage 0 and I Breast Carcinoma
Evaluation of Three Fraction Accelerated Partial Breast Irradiation as the Sole Method of Radiation Therapy for Low-risk Stage 0 and I Breast Carcinoma
Enrollment Status: Active_not_recruiting
Publish Date: March 24, 2025
Intervention Type: Radiation, Procedure
Study Phase: Not Applicable
Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination With Concurrent Lapatinib in Patients With Brain Metastasis From HER2-Positive Breast Cancer - A Collaborative Study of NRG Oncology and KROG
Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination With Concurrent Lapatinib in Patients With Brain Metastasis From HER2-Positive Breast Cancer - A Collaborative Study of NRG Oncology and KROG
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Other, Radiation, Drug
Study Drug: Lapatinib Ditosylate
Study Phase: Phase 2
A Pilot Study Evaluating the Safety and Feasibility of MR-Guided High-Intensity Focused Ultrasound in Conjunction With Radiation Therapy for the Treatment of Locally Advanced Cervical Cancer
A Pilot Study Evaluating the Safety and Feasibility of MR-Guided High-Intensity Focused Ultrasound in Conjunction With Radiation Therapy for the Treatment of Locally Advanced Cervical Cancer
Enrollment Status: Withdrawn
Publish Date: April 01, 2022
Intervention Type: Device, Radiation
Study Phase: Not Applicable
A Prospective Randomized Trial of Sentinel Lymph Node Biopsy Versus no Additional Staging in Patients With Clinical T1-T2 N0 M0 Invasive Breast Cancer and Negative Axillary Ultrasound
A Prospective Randomized Trial of Sentinel Lymph Node Biopsy Versus no Additional Staging in Patients With Clinical T1-T2 N0 M0 Invasive Breast Cancer and Negative Axillary Ultrasound
Enrollment Status: Terminated
Publish Date: March 05, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
A Feasibility Study of Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia in Human Subjects
A Feasibility Study of Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia in Human Subjects
Enrollment Status: Withdrawn
Publish Date: October 06, 2017
Intervention Type: Device
Study Phase: Phase 1
View 8 Less Clinical Trials

54 Total Publications

Long-Term Results of a Phase II Prospective Clinical Trial of Single-Fraction, High-Gradient Adjuvant Partial Breast Irradiation in Early-Stage, Hormone Positive Breast Cancer.
Long-Term Results of a Phase II Prospective Clinical Trial of Single-Fraction, High-Gradient Adjuvant Partial Breast Irradiation in Early-Stage, Hormone Positive Breast Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: March 11, 2025
Similar Doctors
Advanced in Angiosarcoma
Dr. John J. Dombrowski
Radiation Oncology
Advanced in Angiosarcoma
Dr. John J. Dombrowski
Radiation Oncology

Ssm Health Care Group

10101 Woodfield Ln, 
Saint Louis, MO 
 (8.0 miles away)
608-280-4647
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Dombrowski is a Radiation Oncologist in Saint Louis, Missouri. Dr. Dombrowski is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Meningioma, Posterior Fossa Tumor, Radiation Induced Meningioma, and Bone Tumor. Dr. Dombrowski is currently accepting new patients.

Advanced in Angiosarcoma
Dr. Jason M. Edwards
Radiation Oncology
Advanced in Angiosarcoma
Dr. Jason M. Edwards
Radiation Oncology

Physician Specialists Of St Lukes LLC

232 S Woods Mill Rd Sleep Medicine, 
Chesterfield, MO 
 (13.0 miles away)
314-205-6030
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jason Edwards is a Radiation Oncologist in Chesterfield, Missouri. Dr. Edwards is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Melanoma of the Eye, and Thyroid Cancer. Dr. Edwards is currently accepting new patients.

Advanced in Angiosarcoma
Dr. Jenny L. Shaffer
Radiation Oncology
Advanced in Angiosarcoma
Dr. Jenny L. Shaffer
Radiation Oncology

West County Radiological Group Inc

615 S New Ballas Rd, 
Saint Louis, MO 
 (9.8 miles away)
314-251-6031
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Jenny Shaffer is a Radiation Oncologist in Saint Louis, Missouri. Dr. Shaffer is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Pleuropulmonary Blastoma, Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, and Astrocytoma. Dr. Shaffer is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Zoberi's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 35 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile